Nature Reviews Rheumatology

简称 NAT REV RHEUMATOL ·UNITED STATES ·出版周期 Monthly ·年均收录 56 篇

32.7

最新影响因子

2.60%

自引率

较难

投稿难度

较慢,6-12周

审稿周期

期刊简介

Nature Reviews Rheumatology是一本国际知名的风湿病学综述期刊，ISSN号为1759-4790，由Springer Nature出版社出版，出版地为英国，出版周期为月刊。该期刊2022年的影响因子为33.7，属于非开放获取（非OA）期刊，被SCI收录，并在中科院分区中位列医学大类1区。其发文特点以高质量的系统综述和权威评论为主，研究领域涵盖风湿性疾病的发病机制、诊断、治疗及最新研究进展，尤其关注自身免疫性疾病、骨关节炎和炎症性关节病等。杂志以其严谨的学术标准和权威性著称，但投稿难度较高，主要面向领域内的高水平研究人员，审稿周期相对较长，适合追求高影响力发表的学者。

影响因子趋势

近期发表

Antibiotic-induced loss of gut SCFAs exacerbates alphavirus arthritis 2026-09-04

Mitochondrial succinate sensing promotes macrophage inflammation in RA 2026-09-03

Vaccination considerations in autoimmune rheumatic diseases 2026-09-03

CDC42–pyrin interactions promote inflammasome activation and autoinflammatory disease 2026-09-02

ADAR1 variants define an interferon-related subtype of psoriatic disease 2026-09-01

Time to rethink clinical trial design in Sjögren disease 2026-09-01

Air pollution worsens disease activity in RA 2026-08-27

Hepatic control of immunometabolism: implications for the pathogenesis, diagnosis and treatment of rheumatic diseases 2026-08-26

Author Correction: Diagnostic, prognostic and therapeutic biomarkers in rheumatoid arthritis 2026-08-24

Towards a global collaborative approach to living guideline development in rheumatology 2026-08-24